Skip to main content
Tiziana Life Sciences Ltd logo

Tiziana Life Sciences Ltd — Investor Relations & Filings

Ticker · TLSA ISIN · BMG889121031 LEI · 984500769407C5E46F42 US Professional, scientific and technical activities
Open in API
Filings indexed 460 across all filing types
Latest filing 2021-10-21 Regulatory Filings
Country BM Bermuda
Listing US TLSA

About Tiziana Life Sciences Ltd

https://www.tizianalifesciences.com/

Tiziana Life Sciences Ltd. is a clinical-stage biotechnology company focused on developing innovative immunotherapies for neurodegenerative and neuroinflammatory diseases. The company's core strategy involves utilizing alternative drug delivery routes, such as intranasal administration, to modulate the immune system. Its lead clinical candidate, foralumab (TZLS-401), is the only fully human anti-CD3 monoclonal antibody being investigated for neurological conditions. Foralumab is in clinical development for the treatment of Non-Active Secondary Progressive Multiple Sclerosis (na-SPMS), Alzheimer's disease, Amyotrophic Lateral Sclerosis (ALS), and Multiple System Atrophy (MSA). The company's pipeline also includes an anti-IL-6 receptor monoclonal antibody (TZLS-501) for potential application in lung diseases.

Recent filings

Filing Released Lang Actions
CURRENT REPORT
Regulatory Filings Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC, which is used for reporting unscheduled material events or corporate changes. The text describes a corporate reorganization involving a new parent company, share consolidation, delisting of old shares, and listing of new shares on NASDAQ. It includes details about changes in control, amendments to articles of incorporation and bylaws, and shareholder voting results. The document is not a full annual or quarterly report, nor is it an earnings release or audit report. It is not a proxy statement or remuneration report. The primary content is about corporate restructuring and related governance changes, which fits the category of Regulatory Filings (RNS) as it does not fit more specific categories like MANG (management changes) or DLST (delisting announcement) alone, but covers multiple regulatory disclosures in one filing. The document length (15,000 characters) and detailed content confirm it is a full filing, not just an announcement of a report (RPA). Therefore, the best classification is Regulatory Filings (RNS).
2021-10-21 English
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings Classification · 95% confidence The document is a Form 6-K, which is a report of a foreign private issuer filed with the SEC under the Securities Exchange Act of 1934. It contains a regulatory news service announcement about a Share Capital Consolidation and commencement of trading on NASDAQ. The document is relatively short (2967 characters) and primarily serves to furnish an announcement rather than provide detailed financial data or a full report. It explicitly states that the attached announcement is not "filed" for certain regulatory purposes and is being furnished. This aligns with the characteristics of a Regulatory Filings (RNS) document, which is a general regulatory announcement and a fallback category for filings that do not fit other specific categories. It is not an Annual Report, Interim Report, Earnings Release, or any other detailed financial or management report. Therefore, the appropriate classification is Regulatory Filings (RNS).
2021-10-21 English
Delisting Announcement 2021
Delisting Announcement
2021-10-20 English
FORM 6-K
Regulatory Filings Classification · 95% confidence The document is a Form 6-K, which is a report of a foreign private issuer filed with the SEC. It references an attached Regulatory News Service (RNS) Announcement dated October 20, 2021, concerning the Scheme Effective Date. The document itself is short (2715 characters) and primarily serves to furnish the RNS announcement rather than containing substantive financial data or detailed report content. It explicitly states that the attached exhibit is not "filed" for certain regulatory purposes and is being furnished. There is no detailed financial report, management discussion, or other substantive content typical of annual or interim reports. Therefore, this document is best classified as a Regulatory Filing (RNS), which is the fallback category for miscellaneous filings that do not fit other specific categories and includes Form 6-K filings that furnish announcements or information without detailed financial data.
2021-10-20 English
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings Classification · 95% confidence The document is a Form 6-K, which is a report of a foreign private issuer filed with the SEC. It references an attached Regulatory News Service (RNS) announcement about a PDMR Dealing (person dealing in a relevant security). The document itself is short (2907 characters) and primarily serves to furnish the RNS announcement rather than provide detailed financial data or a full report. It also explicitly states that the information is being furnished and not filed for certain regulatory purposes. Given the short length and the nature of the content (an announcement of a regulatory news service release), this fits the criteria for a Regulatory Filings (RNS) classification rather than a full report or other specific filing types.
2021-10-20 English
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings Classification · 95% confidence The document is a Form 6-K, which is a report of a foreign private issuer filed with the SEC. It references a Regulatory News Service (RNS) announcement about a court sanctioning a scheme of arrangement and capital reduction. The document itself is short (2948 characters) and primarily serves to furnish the RNS announcement as an exhibit. It does not contain detailed financial statements or substantive financial data. The text explicitly states that the information is being furnished and shall not be deemed "filed" for certain regulatory purposes, indicating it is an announcement rather than a full report. Therefore, this document fits best under the category of Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory announcements and filings that do not fit other categories.
2021-10-19 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.